购物车
- 全部删除
- 您的购物车当前为空
SD-7300 (SC-81490) 作为一种抑制剂,对MMP-2、MMP-9和MMP-13展示出显著的口服活性,其Ki值分别是0.03、0.01和0.03 nM。通过减少肿瘤细胞对细胞外基质的降解,SD-7300有效抑制肿瘤细胞的侵袭与转移。此化合物还能剂量依赖性地抑制小鼠角膜的血管生成,以及抑制由白细胞介素-1诱导的牛软骨的降解。SD-7300常被应用于乳腺癌的相关研究。
SD-7300 (SC-81490) 作为一种抑制剂,对MMP-2、MMP-9和MMP-13展示出显著的口服活性,其Ki值分别是0.03、0.01和0.03 nM。通过减少肿瘤细胞对细胞外基质的降解,SD-7300有效抑制肿瘤细胞的侵袭与转移。此化合物还能剂量依赖性地抑制小鼠角膜的血管生成,以及抑制由白细胞介素-1诱导的牛软骨的降解。SD-7300常被应用于乳腺癌的相关研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | SD-7300 (SC-81490) functions as an orally active inhibitor targeting MMP-2, MMP-9, and MMP-13, exhibiting potent inhibition with K_i values of 0.03, 0.01, and 0.03 nM, respectively. By inhibiting these metalloproteinases, SD-7300 effectively reduces extracellular matrix degradation by tumor cells, thereby curbing their invasion and metastasis. Additionally, this compound acts as a dose-dependent inhibitor of mouse corneal angiogenesis and prevents interleukin-1-induced degradation of bovine cartilage. SD-7300 is applicable in the study of breast cancer. |
靶点活性 | MMP-9:0.01 nM (Ki), MMP-2:0.03 nM (Ki), MMP-13:0.03 nM (Ki) |
别名 | SC-81490, PF-02881307 |
分子量 | 525.54 |
分子式 | C21H30F3N3O7S |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.